Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000666766 | SCV000791116 | pathogenic | Peroxisome biogenesis disorder type 3B; Peroxisome biogenesis disorder 3A (Zellweger) | 2017-04-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001390433 | SCV001592169 | pathogenic | Peroxisome biogenesis disorder 3A (Zellweger) | 2023-10-30 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg202*) in the PEX12 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX12 are known to be pathogenic (PMID: 9090384, 9632816, 21031596). This variant is present in population databases (rs61752105, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with Zellweger syndrome (PMID: 14571262, 21031596). ClinVar contains an entry for this variant (Variation ID: 551647). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV001390433 | SCV004201438 | pathogenic | Peroxisome biogenesis disorder 3A (Zellweger) | 2024-03-04 | criteria provided, single submitter | clinical testing |